NCT00632866 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome


Sponsors: Assistance Publique - Hôpitaux de Paris Sanofi-Aventis	Phases: Phase III
Indications	Acronym: JOQUER
Primary Sjögren's Syndrome
Age Groups: Adult Senior	Gender: Both
Names: Drug: Hydroxychloroquine Drug: Placebo	Enrollment: 120

Additional information about NCT00632866.